Based on in silico analysis, it has been postulated that RO-AIMs exert their effect by interacting with the DEAH-Box helicase 36 (DHX36) and c-Myc in a ternary complex, halting glioma cell proliferation [410] (Table 1). The gene discussed is MYC; the disease is glioma.